Skip to content
10-K

Annual Report

Deciphera Pharmaceuticals, Inc.

0001654151-23-000003

← back to feed
Filed
Feb 7, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Jan 31, 2023 75.95M sh
Cash And Equivalents FY 2022 · Dec 31, 2021 $87.06M
Current Liabilities FY 2022 · Dec 31, 2021 $96.77M
Total Liabilities FY 2022 · Dec 31, 2021 $124.76M
Current Assets FY 2022 · Dec 31, 2021 $339.01M
Total Assets FY 2022 · Dec 31, 2021 $429.48M
Shares Diluted FY 2022 · Dec 31, 2020 55.78M sh
Capex FY 2022 · Dec 31, 2020 $5.32M
Operating Cash Flow FY 2022 · Dec 31, 2020 −$239.68M
Eps Diluted FY 2022 · Dec 31, 2020 −$4.78
Eps Basic FY 2022 · Dec 31, 2020 −$4.78
Sga Expense FY 2022 · Dec 31, 2020 $114.08M
Rd Expense FY 2022 · Dec 31, 2020 $198.97M
Net Income FY 2022 · Dec 31, 2020 −$266.49M
Operating Income FY 2022 · Dec 31, 2020 −$271.19M
Cost Of Revenue FY 2022 · Dec 31, 2020 $225K
Revenue FY 2022 · Dec 31, 2020 $42.09M
Stockholders Equity FY 2022 · Dec 31, 2019 $546.47M